ArticleBMC plant biology2026
Transcriptional profiling of anthocyanin biosynthesis in variegated and non-variegated dorsal petal regions of Impatiens uliginosa.
Article in BMC plant biology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
Abstract
backgroundPetal variegation is an important ornamental trait in flowering plants and has major implications for both evolutionary biology, because it can promote speciation and diversity, and horticulture, because it enhances aesthetic appeal and commercial value. Here, we used Impatiens uliginosa as a model system and combined morphological, anatomical, physiological, biochemical, transcriptomic, and molecular approaches to investigate the mechanisms underlying petal variegation.
resultsFreehand sectioning revealed that pigments were predominantly localized in the upper epidermal cells. Compared with the non-variegated dorsal petal regions, the variegated dorsal petal regions contained approximately three times as many pigment-accumulating cells; these cells were smaller, more densely arranged, and exhibited higher pigment density per unit area, collectively contributing to the darker coloration of the variegated regions. Pigment-content analysis showed that the variegated dorsal petal regions accumulated significantly higher levels of total carotenoids, anthocyanins, and flavonoids than the non-variegated dorsal petal regions. Semi-quantitative analysis further indicated that anthocyanin-related compounds, particularly delphinidin, pelargonidin, and peonidin derivatives, were enriched in the variegated dorsal petal regions. To investigate the molecular basis of this differential pigmentation, we performed comparative RNA-seq analysis of the variegated and non-variegated dorsal petal regions and identified a suite of candidate genes potentially involved in variegation formation. Functional validation of one candidate, IuMYB114, was carried out using virus-induced gene silencing (VIGS). Silencing of IuMYB114 resulted in a significant reduction in both the size and color intensity of the variegated dorsal petal regions. qRT-PCR analysis confirmed that IuMYB114 expression in silenced plants was only 11% of that in wild-type plants. Moreover, the expression of several key anthocyanin-biosynthetic genes, including IuANS, IuUFGT, and IuF3'5'H, was significantly downregulated in the silenced lines.
conclusionsTaken together, these results suggest that IuMYB114 is likely associated with the positive regulation of anthocyanin biosynthesis and may play an important role in the formation of variegated and non-variegated dorsal petal regions in I. uliginosa, potentially through the regulation of anthocyanin biosynthetic genes. The spatially restricted expression of IuMYB114 may therefore contribute to differential anthocyanin deposition and, consequently, to petal variegation.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.